documents: FDA-2022-D-0697-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-D-0697-0001 FDA FDA-2022-D-0697 Sameness Evaluations in an Abbreviated New Drug Application—Active Ingredients; Draft Guidance for Industry; Availability Notice Notice of Availability 2022-11-09T05:00:00Z 2022 11 2022-11-09T05:00:00Z   2022-11-09T13:49:02Z 2022-24432 0 0 090000648549d539

Links from other tables